Showing 1 posts of 1 posts found.


AstraZeneca jettisons European heart drug rights for $210m

July 24, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Atacand, Cheplapharm, blood pressure, heart failure, pharma

AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …

Latest content